poisar

Stocks · News reference

TD Cowen Downgrades RXO to Sell, Lowers Price Target to $19

BenzingaJul 28, 2026, 3:13 PMBenzinga Newsdesk

TD Cowen analyst Jason Seidl downgrades RXO (NYSE:RXO) from Hold to Sell and lowers the price target from $24 to $19.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 28, 2026, 3:13 PM
Checked
Jul 28, 2026, 3:13 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading